Simplex Trading, LLC Avidity Biosciences, Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$22.73 - $40.85 $52,347 - $94,077	-2,303 Reduced 20.92%	8,703 $355,000
Q1 2024 Apr 25, 2024	BUY	$9.16 - $25.52 $100,814 - $280,873	11,006 New	11,006 $280,000
Q2 2023 Aug 04, 2023	BUY	$10.62 - $17.34 $28,939 - $47,251	2,725 Added 29.47%	11,972 $132,000
Q1 2023 Apr 27, 2023	BUY	$15.35 - $25.65 $121,894 - $203,686	7,941 Added 608.04%	9,247 $141,000
Q4 2022 Feb 02, 2023	BUY	$10.06 - $22.66 $11,810 - $26,602	1,174 Added 889.39%	1,306 $28,000
Q3 2022 Nov 04, 2022	BUY	$15.46 - $23.43 $2,040 - $3,092	132 New	132 $2,000
Q1 2022 May 02, 2022	SELL	$14.2 - $23.78 $1,249 - $2,092	-88 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$20.4 - $28.66 $1,795 - $2,522	88 New	88 $2,000

251

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $1.67B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.